<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.ukri.org:80/organisation/3B1E5961-8677-4A32-B15C-12FB968FA163"><gtr:id>3B1E5961-8677-4A32-B15C-12FB968FA163</gtr:id><gtr:name>University of Pennsylvania</gtr:name><gtr:address><gtr:line1>3451 Walnut Street,</gtr:line1><gtr:line2>Suite P-221</gtr:line2><gtr:line3>Franklin Building</gtr:line3><gtr:line4>Philadelphia</gtr:line4><gtr:postCode>PA 19104</gtr:postCode><gtr:region>Outside UK</gtr:region><gtr:country>United States</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/F724BB81-CAD8-43A7-B2C0-394CD9DE4639"><gtr:id>F724BB81-CAD8-43A7-B2C0-394CD9DE4639</gtr:id><gtr:name>University of California, San Diego</gtr:name><gtr:address><gtr:line1>9500 Gilman Drive</gtr:line1><gtr:line4>La Jolla</gtr:line4><gtr:line5>CA 92093</gtr:line5><gtr:region>Outside UK</gtr:region><gtr:country>United States</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/D1774113-D5D2-4B7C-A412-66A90FE4B96F"><gtr:id>D1774113-D5D2-4B7C-A412-66A90FE4B96F</gtr:id><gtr:name>University of Cambridge</gtr:name><gtr:address><gtr:line1>Lensfield Road</gtr:line1><gtr:line4>Cambridge</gtr:line4><gtr:postCode>CB2 1EW</gtr:postCode><gtr:region>East of England</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/03D8AFBB-3EA5-4885-B036-BD4F9F4F9849"><gtr:id>03D8AFBB-3EA5-4885-B036-BD4F9F4F9849</gtr:id><gtr:name>University of Sheffield</gtr:name><gtr:department>Respiratory Medicine</gtr:department><gtr:address><gtr:line1>Firth Court</gtr:line1><gtr:line2>Western Bank</gtr:line2><gtr:line4>Sheffield</gtr:line4><gtr:line5>South Yorkshire</gtr:line5><gtr:postCode>S10 2TN</gtr:postCode><gtr:region>Yorkshire and The Humber</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/03D8AFBB-3EA5-4885-B036-BD4F9F4F9849"><gtr:id>03D8AFBB-3EA5-4885-B036-BD4F9F4F9849</gtr:id><gtr:name>University of Sheffield</gtr:name><gtr:address><gtr:line1>Firth Court</gtr:line1><gtr:line2>Western Bank</gtr:line2><gtr:line4>Sheffield</gtr:line4><gtr:line5>South Yorkshire</gtr:line5><gtr:postCode>S10 2TN</gtr:postCode><gtr:region>Yorkshire and The Humber</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>FELLOW</gtr:name></gtr:role><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/3B1E5961-8677-4A32-B15C-12FB968FA163"><gtr:id>3B1E5961-8677-4A32-B15C-12FB968FA163</gtr:id><gtr:name>University of Pennsylvania</gtr:name><gtr:address><gtr:line1>3451 Walnut Street,</gtr:line1><gtr:line2>Suite P-221</gtr:line2><gtr:line3>Franklin Building</gtr:line3><gtr:line4>Philadelphia</gtr:line4><gtr:postCode>PA 19104</gtr:postCode><gtr:region>Outside UK</gtr:region><gtr:country>United States</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/F724BB81-CAD8-43A7-B2C0-394CD9DE4639"><gtr:id>F724BB81-CAD8-43A7-B2C0-394CD9DE4639</gtr:id><gtr:name>University of California, San Diego</gtr:name><gtr:address><gtr:line1>9500 Gilman Drive</gtr:line1><gtr:line4>La Jolla</gtr:line4><gtr:line5>CA 92093</gtr:line5><gtr:region>Outside UK</gtr:region><gtr:country>United States</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/D1774113-D5D2-4B7C-A412-66A90FE4B96F"><gtr:id>D1774113-D5D2-4B7C-A412-66A90FE4B96F</gtr:id><gtr:name>University of Cambridge</gtr:name><gtr:address><gtr:line1>Lensfield Road</gtr:line1><gtr:line4>Cambridge</gtr:line4><gtr:postCode>CB2 1EW</gtr:postCode><gtr:region>East of England</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/B50D82FA-B91A-4EEB-85D2-A00E734872E1"><gtr:id>B50D82FA-B91A-4EEB-85D2-A00E734872E1</gtr:id><gtr:firstName>Alfred</gtr:firstName><gtr:otherNames>Arthur</gtr:otherNames><gtr:surname>Thompson</gtr:surname><gtr:orcidId>0000-0002-0717-4551</gtr:orcidId><gtr:roles><gtr:role><gtr:name>FELLOW</gtr:name></gtr:role><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=G0802255"><gtr:id>BA7B0438-7CA5-4CBE-8863-CD949A8A31F6</gtr:id><gtr:title>The Role of HIF-2 in Neutrophilic Inflammation</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Fellowship</gtr:grantCategory><gtr:grantReference>G0802255</gtr:grantReference><gtr:abstractText>Neutrophils are white blood cells that are the first to travel from the blood to areas of infection or damage. They are very important in defending us against infections. However, because they contain many dangerous substances required to kill infectious agents, neutrophils can damage the body?s own tissues if they are over-active or are not removed safely from tissues when their job is done. Over-active neutrophils are important in conditions such as arthritis and lung disease and ways to control their activity could lead to new treatments. 

Neutrophils? activity is regulated by their ability to undergo a suicide process called apoptosis, which switches them off and leads to their safe destruction. One important signal regulating neutrophil suicide is the level of oxygen in their surroundings. Low levels of oxygen increase neutrophil survival and are commonly found in diseased tissues. I aim to study the pathways within neutrophils that prolong their survival when oxygen levels are low and may also regulate their ability to kill bacteria. We know cells sense oxygen levels via a family of proteins called HIF. Using neutrophils lacking different members of this family we hope to understand better how oxygen regulates the functions of these important cells.</gtr:abstractText><gtr:technicalSummary>Neutrophils perform their key roles in innate immune responses at inflamed sites that are typically oxygen deplete. The hypoxia inducible factor (HIF) pathway is known to be central to neutrophil oxygen sensing and responses to hypoxia. Recently, the HIF pathway was also found to regulate inflammation independent of hypoxia. 

A crucial component of the HIF transcription factor, the HIF-alpha subunit (HIF-alpha, has three known isoforms (HIF1-3alpha). HIF-1alpha is required for neutrophil survival in hypoxia. Our preliminary data show unsuspected expression of HIF-2alpha (but not HIF-3alpha) in neutrophils and that its expression is altered in inflammatory disease. 

I hypothesise HIF-1alpha and HIF-2alpha have distinct roles in regulating neutrophil function and apoptosis in response to inflammation and hypoxia. 

I aim to:
(i) Characterise HIF-2alpha mRNA and protein expression in human neutrophils, compared with HIF-1alpha, and their regulation in hypoxia and following inflammatory mediator stimulation. 
(ii) Examine the consequences of HIF-2alpha deficiency, compared with HIF-1alpha deficiency, in neutrophils from wild-type mice and mice with myeloid-targeted deficiency of HIF-1alpha or HIF-2alpha 
(iii) Study in vivo models of inflammation in wild-type, HIF-1alpha and HIF-2alpha deficient mice 
(iv) Study neutrophil function and apoptosis in patients with gain of function mutations in HIF-2alpha and VHL disease

This application builds on evidence HIF-2alpha may regulate neutrophil function and survival and uses a range of approaches (in vitro human and murine neutrophil studies, in vivo models of inflammation and study of informative patient groups) to understand the distinct roles of HIF-1alpha and HIF-2alpha in regulating neutrophilic inflammation. This will enhance understanding of the mechanisms of initiation and resolution of acute inflammation and potentially identify therapeutic targets to limit the exaggerated neutrophil responses associated with inflammatory disease.</gtr:technicalSummary><gtr:fund><gtr:end>2012-08-05</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2009-08-06</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>248956</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Cambridge</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Department of Medicine</gtr:department><gtr:description>University of Cambridge</gtr:description><gtr:id>EDC3FD91-5ABB-4AA5-8059-7C98B20BB2ED</gtr:id><gtr:impact>Publication
McGovern NN et al. Hypoxia selectively inhibits respiratory burst activity and killing of staphylococcus aureus in human neutrophils. Journal of Immunology. Journal of Immunology 2011; 186:453-63.
Thompson AAR. Hypoxia-inducible factor 2a regulates key neutrophil functions in humans, mice and zebrafish. Blood. 2014; 123:366-76.</gtr:impact><gtr:outcomeId>FV4BUJ3Skru-1</gtr:outcomeId><gtr:partnerContribution>Significant intellectual input into your research and access to data</gtr:partnerContribution><gtr:piContribution>Access to data and collaborative experiments</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2009-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of California, San Diego (UCSD)</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:department>Division of Biological Sciences</gtr:department><gtr:description>UCSD &amp;amp; UPenn - Transgenic colonies</gtr:description><gtr:id>D7E48465-8C71-49E4-B7A8-2480C7653F06</gtr:id><gtr:impact>Material transfer agreement</gtr:impact><gtr:outcomeId>Lh3YnUaWtwk-1</gtr:outcomeId><gtr:partnerContribution>Access to transgenic animals</gtr:partnerContribution><gtr:piContribution>Experimental work contributing to collaborator's interests</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2009-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Cambridge</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Department of Physiology, Development and Neuroscience</gtr:department><gtr:description>University of Cambridge</gtr:description><gtr:id>B81C08F0-CCF2-403D-AB2B-58577F4FFDAA</gtr:id><gtr:impact>Publication
McGovern NN et al. Hypoxia selectively inhibits respiratory burst activity and killing of staphylococcus aureus in human neutrophils. Journal of Immunology. Journal of Immunology 2011; 186:453-63.
Thompson AAR. Hypoxia-inducible factor 2a regulates key neutrophil functions in humans, mice and zebrafish. Blood. 2014; 123:366-76.</gtr:impact><gtr:outcomeId>FV4BUJ3Skru-2</gtr:outcomeId><gtr:partnerContribution>Significant intellectual input into your research and access to data</gtr:partnerContribution><gtr:piContribution>Access to data and collaborative experiments</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2009-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Pennsylvania</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:department>Department of Cell and Developmental Biology</gtr:department><gtr:description>UCSD &amp;amp; UPenn - Transgenic colonies</gtr:description><gtr:id>0BFB065B-89D9-4058-865F-E6A6A968EAD0</gtr:id><gtr:impact>Material transfer agreement</gtr:impact><gtr:outcomeId>Lh3YnUaWtwk-2</gtr:outcomeId><gtr:partnerContribution>Access to transgenic animals</gtr:partnerContribution><gtr:piContribution>Experimental work contributing to collaborator's interests</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2009-01-01</gtr:start></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs/><gtr:exploitationOutputs/><gtr:furtherFundingOutputs><gtr:furtherFundingOutput><gtr:amountPounds>29066</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Academy of Medical Sciences Starter Grants for Clinical Lecturers</gtr:description><gtr:end>2016-08-02</gtr:end><gtr:fundingOrg>Academy of Medical Sciences (AMS)</gtr:fundingOrg><gtr:id>034A00A8-C73D-4281-8494-04C164040849</gtr:id><gtr:outcomeId>545899640c6585.25925634</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2014-08-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>750</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>British Lung Foundation GlaxoSmithKline ATS Travel Award</gtr:description><gtr:end>2012-06-02</gtr:end><gtr:fundingOrg>British Lung Foundation (BLF)</gtr:fundingOrg><gtr:id>34293D4E-19D9-4786-875B-0D15FC45A2E9</gtr:id><gtr:outcomeId>cceH5XTrXm6</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2012-05-01</gtr:start></gtr:furtherFundingOutput></gtr:furtherFundingOutputs><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs/><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>0A66A1A4-7F10-4C7A-87A1-90E2C158E8B8</gtr:id><gtr:title>Hypoxia selectively inhibits respiratory burst activity and killing of Staphylococcus aureus in human neutrophils.</gtr:title><gtr:parentPublicationTitle>Journal of immunology (Baltimore, Md. : 1950)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/77ca89656b7c6f8e4560ca051952cf1b"><gtr:id>77ca89656b7c6f8e4560ca051952cf1b</gtr:id><gtr:otherNames>McGovern NN</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0022-1767</gtr:issn><gtr:outcomeId>TQB6UKshU8x</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>6268ECC7-99BE-421C-B173-6EA91D2D7003</gtr:id><gtr:title>Hypoxia-inducible factor 2a regulates key neutrophil functions in humans, mice, and zebrafish.</gtr:title><gtr:parentPublicationTitle>Blood</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a59e42e9d22616597037c27e2e8b3dbf"><gtr:id>a59e42e9d22616597037c27e2e8b3dbf</gtr:id><gtr:otherNames>Thompson AA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0006-4971</gtr:issn><gtr:outcomeId>pm_12884_24_24196071</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>0E7B69D7-F900-4809-8B55-B02809F2A9E8</gtr:id><gtr:title>MET is required for the recruitment of anti-tumoural neutrophils.</gtr:title><gtr:parentPublicationTitle>Nature</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2d7672537d65d15e2dcd473418c63d58"><gtr:id>2d7672537d65d15e2dcd473418c63d58</gtr:id><gtr:otherNames>Finisguerra V</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0028-0836</gtr:issn><gtr:outcomeId>56437c8c9d4b68.37968790</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>5EE00B8F-43A6-4370-B38B-93B354107898</gtr:id><gtr:title>Prolyl hydroxylase 3 (PHD3) is essential for hypoxic regulation of neutrophilic inflammation in humans and mice.</gtr:title><gtr:parentPublicationTitle>The Journal of clinical investigation</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/35319da115a6ef0296e74a6594e5b7f5"><gtr:id>35319da115a6ef0296e74a6594e5b7f5</gtr:id><gtr:otherNames>Walmsley SR</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0021-9738</gtr:issn><gtr:outcomeId>UkMqu9pU9aB</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>3510E54E-ACB5-43D2-9F39-10592374FB24</gtr:id><gtr:title>HIF-mediated innate immune responses: cell signaling and therapeutic implications.</gtr:title><gtr:parentPublicationTitle>Hypoxia (Auckland, N.Z.)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/e734c669ba71bcfd5c480d476b29b372"><gtr:id>e734c669ba71bcfd5c480d476b29b372</gtr:id><gtr:otherNames>Harris AJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>2324-1128</gtr:issn><gtr:outcomeId>54589b77a72bf8.05920416</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>5EA6C6C7-FBE5-4614-BC88-0068F72CF8C8</gtr:id><gtr:title>Hypoxic regulation of neutrophil function and consequences for Staphylococcus aureus infection.</gtr:title><gtr:parentPublicationTitle>Microbes and infection</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/cffb0aef8e1b92df1600b829aea9cc3b"><gtr:id>cffb0aef8e1b92df1600b829aea9cc3b</gtr:id><gtr:otherNames>Lodge KM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>1286-4579</gtr:issn><gtr:outcomeId>589c440fe93449.12402675</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>527B3783-BA02-402E-B7F4-515D45CFD7BA</gtr:id><gtr:title>Deficiency of tumour necrosis factor-related apoptosis-inducing ligand exacerbates lung injury and fibrosis.</gtr:title><gtr:parentPublicationTitle>Thorax</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/8b8cfc7ea3a76b19e21343fd04db9125"><gtr:id>8b8cfc7ea3a76b19e21343fd04db9125</gtr:id><gtr:otherNames>McGrath EE</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0040-6376</gtr:issn><gtr:outcomeId>pm_12884_24_22496351</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F03B34C0-1F53-4308-9EA4-F9EB11C3F327</gtr:id><gtr:title>Mutations in succinate dehydrogenase B (SDHB) enhance neutrophil survival independent of HIF-1a expression.</gtr:title><gtr:parentPublicationTitle>Blood</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/80b6fa8bab35a059b42c83d6782298a1"><gtr:id>80b6fa8bab35a059b42c83d6782298a1</gtr:id><gtr:otherNames>Jones R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0006-4971</gtr:issn><gtr:outcomeId>589c7c0f9d4bf5.06568321</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B3288292-2D7F-464C-B228-FD72948D47BD</gtr:id><gtr:title>Hypoxia, the HIF pathway and neutrophilic inflammatory responses.</gtr:title><gtr:parentPublicationTitle>Biological chemistry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a59e42e9d22616597037c27e2e8b3dbf"><gtr:id>a59e42e9d22616597037c27e2e8b3dbf</gtr:id><gtr:otherNames>Thompson AA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1431-6730</gtr:issn><gtr:outcomeId>589c7c0fc25093.54260115</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>58191714-46BC-46E7-8D4C-844E7285ED27</gtr:id><gtr:title>Hypoxia determines survival outcomes of bacterial infection through HIF-1alpha dependent re-programming of leukocyte metabolism.</gtr:title><gtr:parentPublicationTitle>Science immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a59e42e9d22616597037c27e2e8b3dbf"><gtr:id>a59e42e9d22616597037c27e2e8b3dbf</gtr:id><gtr:otherNames>Thompson AA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>2470-9468</gtr:issn><gtr:outcomeId>589f0901943693.86618818</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>5081137E-E469-4FD9-B6E3-CBFFDB1F5396</gtr:id><gtr:title>A decoy receptor 3 analogue reduces localised defects in phagocyte function in pneumococcal pneumonia.</gtr:title><gtr:parentPublicationTitle>Thorax</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2069e63add5b275198794c2f63a0d84c"><gtr:id>2069e63add5b275198794c2f63a0d84c</gtr:id><gtr:otherNames>Marriott HM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0040-6376</gtr:issn><gtr:outcomeId>pm_12884_24_22735687</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A59DE66E-CAEE-4D99-BBF7-B8890429A5C8</gtr:id><gtr:title>Prolyl hydroxylase 2 inactivation enhances glycogen storage and promotes excessive neutrophilic responses.</gtr:title><gtr:parentPublicationTitle>The Journal of clinical investigation</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6007ed87afc2a745b6fcb42abd8d9fee"><gtr:id>6007ed87afc2a745b6fcb42abd8d9fee</gtr:id><gtr:otherNames>Sadiku P</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0021-9738</gtr:issn><gtr:outcomeId>5a5edac2259f11.74367889</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">G0802255</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>78FE8F42-8AFB-48F8-8662-37D541AD95BF</gtr:id><gtr:percentage>25</gtr:percentage><gtr:text>Congenital Disorders</gtr:text></gtr:healthCategory><gtr:healthCategory><gtr:id>C6D70A71-8796-47BC-AFE0-CC2286E66A06</gtr:id><gtr:percentage>75</gtr:percentage><gtr:text>Inflammatory and Immune System</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>CF950C9A-DB16-4E23-8AEB-94548777BCA1</gtr:id><gtr:percentage>75</gtr:percentage><gtr:text>1.1  Normal biological development and functioning</gtr:text></gtr:researchActivity><gtr:researchActivity><gtr:id>1BF330A9-C7B5-49C5-B54B-CF4FAE6DF1D8</gtr:id><gtr:percentage>25</gtr:percentage><gtr:text>2.1  Biological and endogenous factors</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>